NCT05343078View on ClinicalTrials.gov

Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

October 1, 2022

Conditions
End-stage Renal Disease
Interventions
DRUG

Dapagliflozin 10Mg Tab

Participants will take a single-dose Dapagliflozin 10mg P.O. prior to the hemodialysis session for the single-dose pharmacokinetics protocol. In the multiple-dose protocol, Dapagliflozin 10mg P.O. will be taken daily in the morning for one week.

Trial Locations (1)

13083-887

University of Campinas, Campinas

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER